MoneyWorks4Me

Biocon informs about press release

29 Dec 2017 Evaluate

Biocon has informed about Press Release titled ‘Biocon and Mylans Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through Their Partner Libbs’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..